23 Feb Drug pricing review group signs deal with Aetion for patient data
The Institute for Clinical and
Economic Review (ICER), a small but influential Boston-based
research group, has signed a deal with private technology
company Aetion to help it use patient health data in its reports
on whether individual drugs are priced properly.
Economic Review (ICER), a small but influential Boston-based
research group, has signed a deal with private technology
company Aetion to help it use patient health data in its reports
on whether individual drugs are priced properly.
Sorry, the comment form is closed at this time.